COVID risk prediction algorithm achieves UK regulatory approval
COVID risk prediction algorithm achieves UK regulatory approval
clinical and operational algorithm engine
Chelsea & Westminster Hospitals
Oxford, U.K. 01 March 2021: Sensyne Health plc (LSE: SENS) (“Sensyne” or the “Company” or the “Group”), the UK Clinical AI company, today announces that its SYNE-COV
TM machine learning algorithm for COVID risk prediction has achieved regulatory approval for use in the UK.
About SYNE-COV
SYNE-COV analyses over 60 variables in the patient electronic health record to generate a prediction of the likelihood of a COVID positive patient developing severe disease, requiring ventilation or admission to intensive care. It provides the risk prediction, together with an explanation of the result, to help clinicians manage patients adm
`화이자냐 아스트라제네카냐`…영국서 백신 접종 눈치작전
mk.co.kr - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mk.co.kr Daily Mail and Mail on Sunday newspapers.
화이자냐 아스트라제네카냐 …영국서 백신 접종 눈치작전
donga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from donga.com Daily Mail and Mail on Sunday newspapers.
국내 도입되는 노바백스 백신, 예방효과는 89% 배송·보관 경쟁력
donga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from donga.com Daily Mail and Mail on Sunday newspapers.